Skip to content
Stop using now Drug recall · FDA · Published March 27, 2014

Hospira Potassium Chloride Recall: Particulate Hazard

Hospira recalls 255,900 vials of Potassium Chloride for Inj. Concentrate due to iron oxide particulates. Check your lot number immediately.

🇺🇸 FDA recall #D-1261-2014DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.275 N Field Dr · Lake Forest, IL 60045-2579
✎ GovInfoNow plain-language explainer

What happened, in plain English

Hospira Inc. is recalling Potassium Chloride for Inj. Concentrate, USP, 40 mEq (2 mEq/mL), 20 mL Single-dose Fliptop Vials intended for IV use. The recall was issued because red and black particulate matter, identified as iron oxide, was found within the solution and embedded in the plastic vial. This affects Lot 22-127-DK distributed nationwide. Read more at govinfonow.com/recall/46167-hospira-inc-recalls-potassium-chloride-for-inj-concentrate-usp-40.

Source Summary by GovInfoNow · govinfonow.com/recall/46167-hospira-inc-recalls-potassium-chloride-for-inj-concentrate-usp-40 · Updated October 13, 2026 · FDA enforcement record: FDA #D-1261-2014

Cite this page

“Hospira Potassium Chloride Recall: Particulate Hazard.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46167-hospira-inc-recalls-potassium-chloride-for-inj-concentrate-usp-40. Based on FDA recall #D-1261-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1261-2014%22&limit=1).

Why it’s dangerous

The presence of foreign particulate matter (iron oxide) in an injectable solution poses a risk of embolism or other serious complications if the contaminated fluid is administered into a patient's bloodstream. The particles are visible as red and black specks within the vial.

Who’s affected

Patients receiving intravenous potassium chloride treatment and healthcare providers administering this specific medication are affected. The recall specifically targets units from Lot 22-127-DK.

How to tell if you have this one

Look for Potassium Chloride for Inj. Concentrate, USP, 40 mEq (2 mEq/mL), 20 mL Single-dose Fliptop Vials manufactured by Hospira, Inc. Check specifically for Lot number 22-127-DK. Visually inspect the solution for red and black particulate matter.

  • Brand
    Hospira
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop using the product

    Do not administer or use any vials identified as part of the recalled lot due to the presence of foreign particulates.

  2. Contact your supplier

    Reach out to your pharmaceutical distributor or manufacturer for instructions on returning or disposing of the affected inventory.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 15 months after the firm started it.

1. Firm started the recall: Mar 27, 201412. FDA classified it Class II: Apr 24, 201423. Published in FDA’s Enforcement Report: Apr 30, 201434. FDA terminated the recall: Jun 30, 2015420142015
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

How many units are affected?

Approximately 255,900 vials are subject to this recall.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1261-2014 (March 27, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1261-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA